Global Information
회사소개 | 문의 | 위시리스트

티카그렐러 시장 : 규모, 점유율, 전망, 기회 분석

Ticagrelor Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

리서치사 Coherent Market Insights
발행일 2019년 02월 상품 코드 817576
페이지 정보 영문 157 Pages
가격
US $ 4,500 ₩ 5,250,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,166,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,667,000 PPT Turned PDF (Enterprise User License)


티카그렐러 시장 : 규모, 점유율, 전망, 기회 분석 Ticagrelor Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
발행일 : 2019년 02월 페이지 정보 : 영문 157 Pages

세계의 티카그렐러(Ticagrelor) 시장을 조사했으며, 시장 개요, 종류·용도·지역별 시장 동향, 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인, 시장 기회 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 개요

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약
    • 시장 개요 : 함유량별
    • 시장 개요 : 증상별
    • 시장 개요 : 유통채널별
    • 시장 개요 : 지역별
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
  • 영향 분석
  • 시장 동향
  • 주요 개발
  • 파이프라인 분석
  • 역사적 개요
  • 인수합병
  • 규제 시나리오
  • Five Forces 분석
  • PEST 분석

제4장 티카그렐러 시장 : 함유량별

  • 서론
  • 60mg
  • 90mg

제5장 티카그렐러 시장 : 증상별

  • 서론
  • 급성관 증후군
  • 허혈성 뇌졸중

제6장 티카그렐러 시장 : 유통경로별

  • 서론
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제7장 티카그렐러 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 중남미
  • 아프리카
  • 중동

제8장 경쟁 환경

  • 히트 맵 분석
  • 기업 개요
    • C.H. Boehringer Sohn AG & Ko. KG
    • Pfizer Inc.
    • Eli Lilly and Company
    • AstraZeneca plc
    • Natco Pharma Limited
    • ANHUI HAIKANG PHARMACEUTICAL CO., LTD.
    • Avra Laboratories Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd
  • 애널리스트의 의견

제9장 섹션

  • 참고 문헌
  • 조사 방법
  • Coherent Market Insights에 대해
LSH 19.04.18

Ticagrelor, a drug commonly used as a platelet aggregation inhibitor, received approval from U.S. Food and Drug Administration (USFDA) in July 2011 and in the European Union by the European Commission in December, 2010. Ticagrelor is used for the prevention of thrombotic events such as stroke or heart attack in people with acute coronary syndrome or myocardial infarction with ST wave elevation.

Market Dynamics

Rising prevalence of cardiovascular diseases is attributed to rising geriatric population and changing lifestyles. According to World Health Organization (WHO), around 17.9 million people every year die due to cardiovascular diseases (CVDs), which is about 31% of all global deaths. This is expected to positively impact growth of the ticagrelor market over the next decade.

Furthermore, in September 2016, WHO launched the Global Hearts Initiative through which WHO is supporting governments around the world to improve efforts on CVD prevention and control. Thus, increasing number of non-government and government initiatives, in order to aid in prevention of CVD is expected to help in propelling growth of the ticagrelor market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the ticagrelor market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global ticagrelor market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include C.H. Boehringer Sohn AG & Ko. KG, Pfizer Inc., Eli Lilly and Company, AstraZeneca plc, Natco Pharma Limited, ANHUI HAIKANG PHARMACEUTICAL CO., LTD., Avra Laboratories Pvt Ltd., and Sun Pharmaceutical Industries Ltd
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global ticagrelor market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for ticagrelor market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Ticagrelor Market, By Strength:
    • 60 mg
    • 90 mg
  • Global Ticagrelor Market, By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
  • Global Ticagrelor Market, By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Ticagrelor Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Africa
      • By Country:
    • South Africa
    • Central Africa
    • North Africa
      • By Strength:
    • 60 mg
    • 90 mg
      • By Indication:
    • Acute Coronary Syndrome
    • Ischemic Stroke
      • By Distribution Channel:
    • Hospital pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Company Profiles
    • C.H. Boehringer Sohn AG & Ko. KG *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Pfizer Inc.
    • Eli Lilly and Company
    • AstraZeneca plc
    • Natco Pharma Limited
    • ANHUI HAIKANG PHARMACEUTICAL CO., LTD.
    • Avra Laboratories Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Strength
    • Market Snippet, By Indication
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Pipeline Analysis
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Ticagrelor Market, By Strength, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • 60 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • 90 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Ticagrelor Market, By Indication, 2018- 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Acute Coronary Syndrome
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Ischemic Stroke
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Ticagrelor Market, By Distribution Channel, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Ticagrelor Market, By Regions, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Strength, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • C.H. Boehringer Sohn AG & Ko. KG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • AstraZeneca plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Natco Pharma Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • ANHUI HAIKANG PHARMACEUTICAL CO., LTD.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Avra Laboratories Pvt. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Sun Pharmaceutical Industries Ltd
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q